Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

OCT-Guided PCTA: Does It Offer any Benefits?

For many years, percutaneous transluminal coronary angioplasty (PCTA) has expanded significantly worldwide. However, despite the demonstrated advantages of intravascular ultrasound (IVUS) in terms of minimal luminal area, reduced cardiovascular events, and restenosis, its use is not very common due to various reasons.

ATC guiada por OCT

On the other hand, optical coherence tomography (OCT) offers even higher resolution than IVUS. While there are reports comparing it to angiography, we still lack randomized studies that compare it directly to angiography-guided percutaneous coronary intervention (AG-PCI).

The ILUMIEN IV: OPTIMAL PCI study is a large-scale prospective randomized study (1:1) that compared OCT-guided PCI (OCT-PCI) with angiography-guided PCI (AG-PCI). The study included a total of 1233 patients who underwent OCT-PCI and 1254 patients who underwent AG-PCI with the XIENCE stent.

There were two primary endpoints: the primary efficacy endpoint (PEP E), which referred to the final minimum stent area, and the primary clinical endpoint (PEP C), defined as target lesion failure (TLF) at 2 years, including cardiac death, myocardial infarction, or ischemia-driven target lesion revascularization.

Read also: TAVI-in-TAVI with Balloon-Expandable Valves.

Both patient groups were comparable in terms of characteristics. The average patient age was 65 years, and 78% of subjects were male; 72% had hypertension, 42% had diabetes, 22% had experienced an acute myocardial infarction (AMI), 13% had undergone a previous PCI, and 5% had undergone myocardial revascularization surgery (MRS). The estimated glomerular filtration rate (eGFR) was 79 mL/min, 2.2% of patients were on dialysis, and the ejection fraction was 55%.

Regarding clinical presentation, 14% of patients had silent ischemia, 28% had stable angina, 28% had unstable angina, 24% had non-ST-segment elevation myocardial infarction (NSTEMI), and 6% had recent ST-segment elevation myocardial infarction (STEMI). There were no significant differences in terms of medical treatment received.

Furthermore, there were no differences between the groups regarding predilation, the number of treated vessels, or the number of stents implanted. However, procedure time, fluoroscopy time, and contrast volume administered were slightly higher in the OCT-PCI group.

Read also: ROTA.shock Outcomes: Intravascular Lithotripsy vs. Rotational Atherectomy.

In terms of results, the PEP E favored the OCT-PCI group, with a minimum stent area of 5.72 ± 2.04 mm2 compared with 5.36 ± 1.87 mm2 in the AG-PCI group (mean difference = 0.36 mm2; 95% confidence interval [CI], 0.21 to 0.51; P <0.001). However, there were no significant differences in the PEP C (7.4% vs. 8.2%; hazard ratio, 0.90; 95% CI, 0.67 to 1.19; P = 0.45). There were also no differences in terms of cardiac death, myocardial infarction, or ischemia-driven target lesion revascularization.

Conclusion

Patients undergoing OCT-guided PCI had a significantly larger minimum stent area compared with those guided by angiography. However, there were no apparent differences in major cardiovascular events at 2 years (TLF).

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Optical Coherence Tomography–Guided versus Angiography-Guided PCI.

Reference: Ziad A. Ali, et al. NEJM DOI: 10.1056/NEJMoa2305861.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...